Answers are grounded in this paper and cite their sources.
Retrospective cohort study identifies predictors and evaluates outcomes of SRSE in autoimmune encephalitis, suggesting effective neurocritical care strategies.
Background: Super-refractory status epilepticus (SRSE) is the most devastating complication of autoimmune encephalitis (AIE). While the morbidity of AIE-driven status is recognized, data quantifying independent early clinical predictors remains scarce, leading to critical delays in immunomodulatory escalation. Objective: To identify independent baseline predictors of SRSE in AIE and evaluate longitudinal functional recovery to guide neurocritical care. Methods: A retrospective cohort study of 222 patients meeting the Graus criteria for AIE was conducted at a tertiary referral center (2015–2024). Patients were stratified into SRSE ( n = 17) and non-SRSE ( n = 205) cohorts. To mitigate quasi-complete separation, variables with 100% prevalence were excluded from multivariable analysis. A multivariate logistic regression model quantified independent risk factors. Functional outcomes were assessed longitudinally using the modified Rankin Scale (mRS). Results: SRSE occurred in 7.6% of the cohort, exclusively within seronegative or nonclassical antibody presentations. In multivariate analysis adjusting for early clinical and radiological signs, severe encephalopathy at presentation (Glasgow Coma Scale < 13) emerged as the strongest independent predictor (adjusted odds ratio [aOR] 18.51, 95% confidence interval [CI] 3.97–86.36, p < 0.001). An abnormal initial magnetic resonance imaging was also a robust independent risk factor (aOR 8.84, 95% CI 1.08–72.19, p = 0.042). Seizures acting as an index symptom demonstrated a strong univariate trend but lost independent significance in the adjusted model ( p = 0.074). Short-term morbidity was profound: 100% of the SRSE cohort required mechanical ventilation, and 76.5% exhibited poor functional outcomes (mRS > 2) at discharge. However, longitudinal tracking revealed a profound delayed-recovery phenotype. By 1 year, the rate of good functional outcomes (mRS 0–2) in surviving SRSE patients (83.3%) achieved statistical equivalence with the non-SRSE cohort (92.3%, p = 0.582). Conclusion: Early encephalopathy and abnormal neuroimaging are powerful independent predictors of SRSE. Despite catastrophic acute morbidity, sustained neurocritical care and early immunomodulation yield excellent, long-term functional reversibility. Publication History Article published online: 15 July 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Private Limited A-13A, Graphix Tower 1, 6th floor, Sector 62, Noida 201309, Uttar Pradesh, India
No takes yet. Share an insight, caveat, or question.
Swathy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: